Global Health & Respiratory Disease Burden

Addressing disparities and building resilient systems, global health & respiratory disease burden focuses on the intersection of epidemiology, healthcare access, and socio-economic factors influencing lung health. Low- and middle-income countries disproportionately shoulder the burden of respiratory diseases such as tuberculosis, COPD, and indoor air pollution-induced asthma. Strategic investments in infrastructure, vaccination, diagnostics, and clean air initiatives are essential to reduce preventable mortality. Global Health & Respiratory Disease Burden also involves collaborative surveillance, transnational research partnerships, and WHO-driven frameworks to harmonize care standards globally. The emergence of climate-related respiratory threats and post-pandemic gaps in pulmonary care access further complicate the global landscape. Bridging the health equity gap requires integrated public health interventions, culturally adapted education, and robust policy implementation at local and international levels.